Laboratories, MRI and Dialysis Deals Fared Just Fine in Q4

Laboratories, MRI and Dialysis Deals Fared Just Fine in Q4

by | Jan 6, 2020 1:23 pm | Laboratories, MRI & Dialysis | 0 comments

A few final deals are still rolling in for the last month of 2019, and it seems like the Laboratories, MRI & Dialysis sector fared well. Deal count was down from Q4 2018, 14 this quarter compared to a total of 19 in Q4 2019. However, dollar volume is higher, buoyed by a few large transactions. Cinven and Astorg, two private equity firms, teamed up for the largest transaction of the sector in Q4, purchasing LGC Group for roughly $3.88 billion, according to a report in Private Equity News. LGC provides a range of measurement tools, proficiency testing schemes, supply chain assurance standards, and specialty genomics reagents to the life sciences industry in over 22 countries. KKR (NYSE:... Read More »
Thermo Fisher Sells Its Anatomical Pathology Business

Thermo Fisher Sells Its Anatomical Pathology Business

by | Jan 31, 2019 12:15 pm | Laboratories, MRI & Dialysis | 0 comments

Shortly before it reported fourth quarter and full-year earnings results, Thermo Fisher Scientific (NYSE: TMO) announced the sale of its anatomical pathology (AP) business for $1.14 billion. The buyer, Tokyo-based PHC Holdings Corporation, is a global healthcare company developing and manufacturing medical equipment and products across diabetes care, diagnostics, life sciences and healthcare information technology. Its consolidated net sales in FY2017 was approximately $1.76 billion. The AP business provides microscope slides, instruments and consumables. It has approximately 1,200 employees at locations in the U.S., Europe and China. The business generates approximately $350 million in... Read More »